Evaluation of blood stream infections by Candida in three tertiary hospitals in Salvador, Brazil: A case-control study

Brazilian Journal of Infectious Diseases

Volumn 10, Issue 1, 2006, Pages 36-40

  Barberino, Maria Goreth ^a   Silva, Nanci ^b,e   Rebouças, Carla ^c   Barreiro, Katarine ^a   Alcântara, Ana Paula ^d   Netto, Eduardo M ^c   Albuquerque, Lígia ^c   Brites, Carlos ^b,c  

^a Hospital Alianca   (Brazil)

^b Hospital Espanhol   (Brazil)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^d Hospital Santo Amaro   (Brazil)

^e NONE   (Brazil)

Author keywords

Bacteremia; Invasive candidiasis; Risk factors

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID;

ADULT; AGED; ARTICLE; BLOOD CULTURE; BRAZIL; CANDIDA; CANDIDA ALBICANS; CANDIDA FORMATA; CANDIDA GLABRATA; CANDIDA GUILLERMONDI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CASE CONTROL STUDY; CENTRAL VENOUS CATHETER; CHRONIC KIDNEY FAILURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EXPOSURE; FEMALE; FUNGEMIA; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HOSPITALIZATION; HUMAN; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PARENTERAL NUTRITION; PRIVATE HOSPITAL; RETROSPECTIVE STUDY; RISK FACTOR; TERTIARY HEALTH CARE; UNIVARIATE ANALYSIS;

BRAZIL; CANDIDIASIS; CASE-CONTROL STUDIES; CROSS INFECTION; FEMALE; FUNGEMIA; HOSPITALS, PRIVATE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33745083963     PISSN: 14138670     EISSN: 14138670     Source Type: Journal    
DOI: 10.1590/S1413-86702006000100008     Document Type: Article

References (24)

1. Asmunds Dottir L.R., Erlends Dottir H., Gott Fredsson M. Increasing incidence of Candidemia: Results from a 20 -Year Nationwide study in Iceland. J0 Clin Microbiol 2002;40:3489-92.
2. Wise G.J., Silver D.A. Fungal Infections of the Genitourinary System. J Urol 1993;149:1377-88.
3. Fraser V.J., Jones M., Dunkel J., et al. Candidemia in Tertiary care Hospital: Epidemiology, Risk Factors and Predictors of mortality. Clin Infect Dis 1992;15:414-21.
4. Girmenia C., Martiwo P. Fluconazol and the Changing Epidemiology of candidemia. Clin Infect Dis 1998;27:232-4.
5. Rancel Frausto M.S., Wiblin T., et al. National Epidemiology of Mycosis Survey (Nemis): Variations in Rates of Candidal Bloodstream Infections in seven Surgical Icus and six Neonatal Icus. Clin Infect dis 1999;29:253-8.
6. Pfaler M.A., Messer S.A., Houston A., et al. National Epidemiology of Mycoses Survey: A Multicenter Study of Strain Variation an Antifungal Susceptibility Among Isolates of Candida Species. Diagn Microbiol Infect Dis 1998;31:289-96.
7. Colombo A.L., Perfect J., Dinubile M., et al. Global Distribution and Outcomes for Candida Species causing invasive Candidiasis: Results from an International Randomized Double-Blind Study of Casponfungin Versus Amphotericin B for the treatment of invasive Candidiasis. European journal of Clinical Microbiology and Infectious Diseases 2003;22:470-4.
8. Bodey G.P. Hematogenous and major organ candidiasis. In Candidiasis: pathogenesis, diagnosis and treatment, Raven Press Ltd., New York, 1993.
9. Bodgen E., Kessel J. Monilial Meningitis. Arch Pathol 1937;23:909-12.
10. Joachim H., Polayes S. Aubacute Endocarditis and Systemic Mycosis (Monilia). Jama 1940; 115:205-2004.
11. Hurley R. Acute Disseminated Septicemic Moniliasis in adults an children. Postgrad Med J 1964;40:644-53.
12. Edwards J.R. Jr. Invasive Candida Infections. Evolution of a Fungal Pathogen. N Engl J Med 1991;324:1060-2.
13. Fridkin S.K., Jarvis W.R. Epidemiology of Nososcomial Funcal infecuons. Clin Microbiol Rev 1996;9:499-511.
14. Wey S.B., Mori M., Pfaller M.A., et al. Hospital-Acquired Candidemia. The Attributable Mortality and Excess Length of Stay. Archives of Internal Medicine 1998;48:2642-5.
15. Beck-Sague C., Jarvis W.R., National Nosocomial Infections Surveillance System. Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990. Journal of Infections Diseases 1993; 167:1247-51.
16. Banerjee S.N., Emori T.G., Culver D.H., et al. Secular Trends in Nosocomial Primary Bloodstream Infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. American Journal of Medicine 1991;91:865-95.
17. Vazquez J.A., Sanchez V, Dembry L.M., et al. Nosomial Acquisition of Candida Albicans: An Epidemiologic Study. J Infect Dis 1993; 168:195-201.
18. Bross J., Talbot G.H., Maislin G., et al. Risk Factors for Nosocomial Candidemia: A Case-Control Study in adults Without leukemia. Am J Med 1989;87:61-4.
19. Colombo A.L., Nucci M., Salomñao R., et al. High Rate of Non-Albicans Candidemia in Brazilian Tertiary Care Hospitals. Diagnostic Microbiology and Infections Diseases 1999;34:281-6.
20. Karabinis A., Hill C., Leclerca B., et al. A Risk factors for Candidemia in cancer patients: A Case-Control Study. J Clin Microbiol 1988;26:429-32.
21. Nucci M., Colombo A.L. Risk Factors for Breakthrough Candidemia. EUR J Clin Microbiol Infect Dis 2002;21:209-11.
22. Botas C.M., Kurlat J., Young S.M., Sola A. Disseminated Candidal Infectious and Intravenous Hydrocortisone in Preterm Infants. Pediatrics 1995;95:883-7.
23. Abi-Said D., Anaissie E., Uzun O., et al. the Epidemiology of Hematogenous Candidiasis By Different Candida Species. Clin Infect dis 1997;24:1122-8.
24. Blot S.I., Vandewoude K.H., Hoste E.A., Colardyn F.A. Effcts of nosocomial Candidemia on outcomes of Critically Ill Patients. Am J Med 2002; 113;480-5.